Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Tilt the vial slightly as you rotate it
The Pharma Years In 1993, a Croatian pharmaceutical company called PLIVA licensed it, and they ran a human clinical trial
Comparison to Other Senolytic Therapies To contextualise FOXO4-DRI, lets compare it to other senolytic approaches or peptides you may be aware of (helpful given your clinics peptide focus)
After subcutaneous injection, PT-141 typically takes 30 to 60 minutes to take effect
This is a critical differentiator, especially for aging adults or individuals managing coexisting health conditions who are wary of aggressive formulations that can disrupt sleep, raise blood pressure, or cause jittery side effects
Setting appropriate expectations improves treatment adherence and patient satisfaction
.jpg)